Campath

Campath (generic name: alemtuzumab) is a medication used to treat certain blood cancers and multiple sclerosis. It works by targeting and destroying specific immune cells involved in disease processes, helping to reduce disease activity and progression. Campath is administered through injections, usually in a hospital or clinic setting, and may cause side effects like infections or symptoms related to immune system changes. It is typically used when other treatments haven't been effective, and its use is carefully monitored by healthcare providers to balance benefits and potential risks.